Showing results (61-70 of 643) with videos related to
Sort By:
Pageof 65
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 4, 2024
An emerging role for the gut microbiome in tauopathyYiyang Zhu, Wade K Self, David M HoltzmanThe Journal of Experimental Medicine|July 20, 2016
Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?Molly Stanley, Shannon L Macauley, David M HoltzmanNature Immunology|June 29, 2026
Adaptive immunity in the pathogenesis of neurodegenerationYongyi Li, Jason D Ulrich, David M HoltzmanDevelopmental Neuroscience|March 18, 2003
Evidence that p38 mitogen-activated protein kinase contributes to neonatal hypoxic-ischemic brain injuryByung Hee Han, Junjeong Choi, David M HoltzmanCurrent Opinion in Neurobiology|December 17, 2025
Context matters: Conflicting roles of interferon-γ signaling in CNS diseasesJonathan Nulman, Jason D Ulrich, David M HoltzmanJournal of Neuropathology and Experimental Neurology|January 18, 2012
Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic miceHien T Tran, Laura Sanchez, David L BrodyPlos One|October 18, 2022
Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer's related amyloid-beta pathologyShiran Su, Thomas J Esparza, David L BrodyMolecular Neurodegeneration|December 22, 2018
New insights into the role of TREM2 in Alzheimer's diseaseMaud Gratuze, Cheryl E G Leyns, David M HoltzmanThe Lancet. Neurology|February 26, 2011
Apolipoprotein E in Alzheimer's disease and other neurological disordersPhilip B Verghese, Joseph M Castellano, David M HoltzmanScience Translational Medicine|April 8, 2011
Alzheimer's disease: the challenge of the second centuryDavid M Holtzman, John C Morris, Alison M GoatePageof 65